Abstract
Background: Heliomycin (resistomycin), an antibiotic with broad spectra of biological activities including antimicrobial, antifungal, antiviral, and antiproliferative. However, an extremely low solubility in aqueous media and in the majority of organic solvents limits its practical application.
Objective: Due to a high practical potential of heliomycin, new routes of structural modification are strongly required to improve its solubility.
Conclusion: The patent claims a series of 4-aminomethyl derivatives of heliomycin as well as a pharmaceutical composition based on it. Application of Mannich aminomethylation allowed to diversify the structure of initial antibiotic and to obtain the derivatives with significantly improved water solubility and a potent antiproliferative efficacy.
Keywords: Aminomethylation, anticancer agents, heliomycin, improved solubility, Mannich reaction, resistomycin.
Recent Patents on Anti-Cancer Drug Discovery
Title:Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency
Volume: 13 Issue: 4
Author(s): Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*
Affiliation:
- Gause Institute of New Antibiotics, 11 B. Pirogovskaya Street, Moscow 119021,Russian Federation
Keywords: Aminomethylation, anticancer agents, heliomycin, improved solubility, Mannich reaction, resistomycin.
Abstract: Background: Heliomycin (resistomycin), an antibiotic with broad spectra of biological activities including antimicrobial, antifungal, antiviral, and antiproliferative. However, an extremely low solubility in aqueous media and in the majority of organic solvents limits its practical application.
Objective: Due to a high practical potential of heliomycin, new routes of structural modification are strongly required to improve its solubility.
Conclusion: The patent claims a series of 4-aminomethyl derivatives of heliomycin as well as a pharmaceutical composition based on it. Application of Mannich aminomethylation allowed to diversify the structure of initial antibiotic and to obtain the derivatives with significantly improved water solubility and a potent antiproliferative efficacy.
Export Options
About this article
Cite this article as:
Nadysev Y. Georgy , Tikhomirov S. Alexander , Dezhenkova G. Lyubov and Shchekotikhin E. Andrey*, Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency, Recent Patents on Anti-Cancer Drug Discovery 2018; 13 (4) . https://dx.doi.org/10.2174/1574892813666180723150542
DOI https://dx.doi.org/10.2174/1574892813666180723150542 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Stem Cell Defects in Philadelphia Chromosome Negative Chronic Myeloproliferative Disorders: A Phenotypic and Molecular Puzzle?
Current Stem Cell Research & Therapy The Role of Oxaliplatin-Based Versus Cisplatin-Based Regimens in Advanced Gastric Cancer: A Systematic Review and Pooled Analysis of the Chinese Literature
Current Cancer Therapy Reviews Patent Selections
Recent Patents on Biomarkers Stem Cell-Mediated Gene Delivering for the Treatment of Cerebral Ischemia: Progress and Prospectives
Current Drug Targets Synthetic Approaches to the 2006 New Drugs
Mini-Reviews in Medicinal Chemistry Thyroid Nodules: Too Many Fine Needle Biopsies?
Current Medical Imaging Pharmaceutical Applications of Graphene-based Nanosheets
Current Pharmaceutical Biotechnology Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents
Current Pharmaceutical Biotechnology Editorial [Hot topic: Special Edition Myeloproliferative Neoplasia – Disease Pathogenesis and Treatment Options (Guest Editors: D. Wolf and H. Rumpold)]
Current Cancer Drug Targets Radiation-Induced Neuroinflammation and Radiation Somnolence Syndrome
CNS & Neurological Disorders - Drug Targets Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases
Current Drug Targets Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids
Current Drug Metabolism Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry Cutting the Limits of Aminobisphosphonates: New Strategies for the Potentiation of their Anti-Tumour Effects
Current Cancer Drug Targets Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry The Calcium-Sensing Receptor as a Regulator of Cellular Fate in Normal and Pathological Conditions
Current Molecular Medicine Respiratory Stem Cells and Progenitors: Overview, Derivation, Differentiation, Carcinogenesis, Regeneration and Therapeutic Application
Current Stem Cell Research & Therapy Perspectives on Medicinal Properties of Mangiferin
Mini-Reviews in Medicinal Chemistry Therapeutic Application of Natural Medicine Monomers in Cancer Treatment
Current Medicinal Chemistry Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design